Structure |
Chemical Name |
CAS |
MF |
![Tadalafil Impurity 35](/CAS/20210111/GIF/749864-17-3.gif) |
Tadalafil Impurity 35 |
749864-17-3 |
C20H18N2O4 |
![Epinastine Impurity 1 HCl](/CAS/20210111/GIF/141342-71-4.gif) |
Epinastine Impurity 1 HCl |
141342-71-4 |
C15H15N3O2 |
![Flurbiprofen Impurity 5](/CAS/20211123/GIF/124635-84-3.gif) |
Flurbiprofen Impurity 5 |
124635-84-3 |
C18H19FO4 |
![Diazepam Impurity 3](/CAS/20200611/GIF/176796-46-6.gif) |
Diazepam Impurity 3 |
176796-46-6 |
C17H17ClN2O2 |
![Pitavastatin Impurity 19 Sodium Salt](/CAS/20210111/GIF/1980814-87-6.gif) |
Pitavastatin Impurity 19 Sodium Salt |
1980814-87-6 |
C25H24FNO5 |
![N-(4-(4-fluorophenyl)-5-((E)-2-((2R,4R)-4-hydroxy-6- oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin- 2-yl)-N-methylmethanesulfonamide](/CAS/20200401/GIF/CB74849839.gif) |
N-(4-(4-fluorophenyl)-5-((E)-2-((2R,4R)-4-hydroxy-6- oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin- 2-yl)-N-methylmethanesulfonamide |
|
C22H26FN3O5S |
![Fulvestrant EP Impurity E](/CAS/20211123/GIF/2170200-14-1.gif) |
Fulvestrant EP Impurity E |
2170200-14-1 |
C32H45F5O3S |
![Edaravone Impurity 16](/) |
Edaravone Impurity 16 |
|
|
![Linagliptin Impurity 50](/) |
Linagliptin Impurity 50 |
|
|
![Phenacetin Impurity 3](/CAS/20200401/GIF/24176-84-9.gif) |
Phenacetin Impurity 3 |
24176-84-9 |
C14H13ClN2O2 |
![2-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-1-ol](/CAS/20200401/GIF/109632-11-3.gif) |
2-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-1-ol |
109632-11-3 |
C15H25NO3 |
![Pabuxilibu impurities](/) |
Pabuxilibu impurities |
|
|
![ERYTHROMYCIN IMPURITY G](/) |
ERYTHROMYCIN IMPURITY G |
|
|
![Amylmetacresol EP impurity E](/) |
Amylmetacresol EP impurity E |
|
|
![(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanamide](/CAS/20200401/GIF/2232201-72-6.gif) |
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanamide |
2232201-72-6 |
C11H18N2O3 |
![methyl 1-hydroxy-2-oxoindoline-6-carboxylate](/CAS/20200401/GIF/1895918-24-7.gif) |
methyl 1-hydroxy-2-oxoindoline-6-carboxylate |
1895918-24-7 |
C10H9NO4 |
![Dapagliflozin Impurity (MW: 437Da)](/) |
Dapagliflozin Impurity (MW: 437Da) |
|
|
![Cetirizine Impurity BHA](/) |
Cetirizine Impurity BHA |
|
|
![Cilastatin EP Impurity H](/) |
Cilastatin EP Impurity H |
|
|
![Febuxostat Impurity 130](/CAS/20200515/GIF/1643131-93-4.gif) |
Febuxostat Impurity 130 |
1643131-93-4 |
C20H25NO5S |
![(2-Chlorophenyl)diphenylmethanol](/) |
(2-Chlorophenyl)diphenylmethanol |
|
|
![Nilotinib Impurity 27](/CAS/20210111/GIF/1807606-80-9.gif) |
Nilotinib Impurity 27 |
1807606-80-9 |
C28H22F3N7O2 |
![Vonoprazan Impurity 53](/) |
Vonoprazan Impurity 53 |
|
|
![Vonoprazan Impurity 61](/) |
Vonoprazan Impurity 61 |
|
|
![Emtricitabine Ring-opening Impurity](/) |
Emtricitabine Ring-opening Impurity |
|
|
![Tafluprost Impurity 1 (Tafluprost (1S,2S,3S,5R)-Isomer)](/) |
Tafluprost Impurity 1 (Tafluprost (1S,2S,3S,5R)-Isomer) |
|
|
![Escitalopram Butyryl Impurity](/CAS/20210111/GIF/1803244-58-7.gif) |
Escitalopram Butyryl Impurity |
1803244-58-7 |
C25H33FN2O2 |
![Oseltamivir isomer impurity](/) |
Oseltamivir isomer impurity |
|
|
![SULPIRIDE IMPURITY B](/) |
SULPIRIDE IMPURITY B |
|
|
![1,2-Dihydro Diethyl Loteprednol Carbonate](/) |
1,2-Dihydro Diethyl Loteprednol Carbonate |
82048-81-5 |
C26H36O9 |
![Nilotinib 3-Imidazolyl N-oxide](/CAS/20210111/GIF/2139382-75-3.gif) |
Nilotinib 3-Imidazolyl N-oxide |
2139382-75-3 |
C28H22F3N7O2 |
![α,α''-[(Methylimino)di-2,1-ethanediyl]bis-benzenemethanol](/) |
α,α''-[(Methylimino)di-2,1-ethanediyl]bis-benzenemethanol |
857786-66-4 |
C19H25NO2 |
![Pramipexole 828 Impurity](/) |
Pramipexole 828 Impurity |
|
|
![E-Ceftazidime Oxide Impurity](/) |
E-Ceftazidime Oxide Impurity |
|
|
![Cefuroxime Impurity D Δ3-Isomer](/) |
Cefuroxime Impurity D Δ3-Isomer |
|
|
![Ampicillin Open-Ring Formylation Impurity](/) |
Ampicillin Open-Ring Formylation Impurity |
|
|
![Faropenem Degradation Impurity A](/) |
Faropenem Degradation Impurity A |
|
|
![2-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid](/) |
2-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid |
|
|
![(2S)-dimethyl 2-(4-(4-oxobutan-2-yl)benzamido)pentanedioate](/) |
(2S)-dimethyl 2-(4-(4-oxobutan-2-yl)benzamido)pentanedioate |
|
|
![(E)-1-(2,4-difluorostyryl)-1H-1,2,4-triazole](/) |
(E)-1-(2,4-difluorostyryl)-1H-1,2,4-triazole |
|
|
![Peramivir Impurity 22](/) |
Peramivir Impurity 22 |
|
|
![Olaparib Impurity 58](/CAS/20210111/GIF/848136-41-4.gif) |
Olaparib Impurity 58 |
848136-41-4 |
C22H21FN4O3 |
![Fluconazole Impurity 4](/CAS/20210111/GIF/168479-96-7.gif) |
Fluconazole Impurity 4 |
168479-96-7 |
C10H7F2N3O |
![Roxatidine Impurity 7](/CAS/20210111/GIF/876497-65-3.gif) |
Roxatidine Impurity 7 |
876497-65-3 |
C7H6N2O2 |
![Sparfloxacin Impurity](/CAS/20210111/GIF/126457-99-6.gif) |
Sparfloxacin Impurity |
126457-99-6 |
C19H21F2N3O3 |
![Peramivir Impurity 39](/) |
Peramivir Impurity 39 |
|
|
![Imatinib impurity 39](/) |
Imatinib impurity 39 |
|
|
![7-(4-ブロモブトキシ)キノリン-2(1H)-オン](/StructureFile/ChemBookStructure22/GIF/CB7648430.gif) |
7-(4-ブロモブトキシ)キノリン-2(1H)-オン |
203395-59-9 |
C13H14BrNO2 |
![DESMETHYL ATOMOXETINE HYDROCHLORIDE](/CAS/GIF/881995-46-6.gif) |
DESMETHYL ATOMOXETINE HYDROCHLORIDE |
881995-46-6 |
C16H19NO.ClH |
![2-ヒドロキシ-5-ベンジルオキシアセトフェノン](/CAS/GIF/30992-63-3.gif) |
2-ヒドロキシ-5-ベンジルオキシアセトフェノン |
30992-63-3 |
C15H14O3 |
![2-[(4-METHOXY-3-METHYL-2-PYRIDINYL)-METHYLTHIO]-BENZIMIDAZOLE](/CAS/GIF/102804-82-0.gif) |
2-[(4-METHOXY-3-METHYL-2-PYRIDINYL)-METHYLTHIO]-BENZIMIDAZOLE |
102804-82-0 |
C15H15N3OS |
![2-[(4-METHYLPIPERAZIN-1-YL)METHYL]BENZONITRILE](/CAS/GIF/864069-00-1.gif) |
2-[(4-METHYLPIPERAZIN-1-YL)METHYL]BENZONITRILE |
864069-00-1 |
C13H17N3 |
![Sugammadex sodium Impurity 40](/) |
Sugammadex sodium Impurity 40 |
|
|
![Sugammadex sodium Impurity 44](/) |
Sugammadex sodium Impurity 44 |
|
|
![Sugammadex sodium Impurity 49](/) |
Sugammadex sodium Impurity 49 |
|
|
![Cefazolin Impurity EP-E](/) |
Cefazolin Impurity EP-E |
|
|
![Canagliflozin Impurity 70](/) |
Canagliflozin Impurity 70 |
|
|
![Dapoxetine impurity 66](/) |
Dapoxetine impurity 66 |
|
|
![Gadobutrol Impurity 3](/) |
Gadobutrol Impurity 3 |
|
|
![Empagliflozin Impurity 84](/) |
Empagliflozin Impurity 84 |
|
|
![Iohexol Impurity O](/) |
Iohexol Impurity O |
|
|
![(2,5-dichlorophenyl)(4-ethoxyphenyl)methanone](/CAS/20200611/GIF/1097076-93-1.gif) |
(2,5-dichlorophenyl)(4-ethoxyphenyl)methanone |
1097076-93-1 |
C15H12Cl2O2 |
![Vardenafil Acetyl Analogue](/CAS/GIF/1261351-28-3.gif) |
Vardenafil Acetyl Analogue |
1261351-28-3 |
C25H34N6O3 |
![fenofibrate iMpurity](/) |
fenofibrate iMpurity |
|
|
![11-O-メチルクラリスロマイシン](/CAS/GIF/81103-14-2.gif) |
11-O-メチルクラリスロマイシン |
81103-14-2 |
C39H71NO13 |
![りん酸ENT-オセルタミビル](/CAS/GIF/1035895-89-6.gif) |
りん酸ENT-オセルタミビル |
1035895-89-6 |
C16H29N2O8P |
![3-cyano-4-isobutoxybenzaMide](/CAS/20150408/GIF/161718-85-0.gif) |
3-cyano-4-isobutoxybenzaMide |
161718-85-0 |
C12H14N2O2 |
![カフェイジン酸](/CAS/GIF/54536-15-1.gif) |
カフェイジン酸 |
54536-15-1 |
C8H12N4O3 |
![1-Keto BaMbuterol](/CAS/20211123/GIF/112935-94-1.gif) |
1-Keto BaMbuterol |
112935-94-1 |
C18H27N3O5 |
![デスフルオロエゼチミベ](/CAS/GIF/302781-98-2.gif) |
デスフルオロエゼチミベ |
302781-98-2 |
C24H22FNO3 |
![5-(2-Bromo-1-oxobutyl)-8-hydroxy-2(1H)-quinolinone](/CAS/GIF/59827-93-9.gif) |
5-(2-Bromo-1-oxobutyl)-8-hydroxy-2(1H)-quinolinone |
59827-93-9 |
C13H12BrNO3 |
![Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid)](/CAS/20210111/GIF/39925-19-4.gif) |
Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) |
39925-19-4 |
C8H11N3O6 |
![3-(3-TRIFLUOROMETHYL-PHENYL)-PROPYLAMINE](/CAS/GIF/104774-87-0.gif) |
3-(3-TRIFLUOROMETHYL-PHENYL)-PROPYLAMINE |
104774-87-0 |
C10H12F3N |
![セルトラリンケトン](/CAS/GIF/124379-29-9.gif) |
セルトラリンケトン |
124379-29-9 |
C16H12Cl2O |
![(4-(2-(アゼパン-1-イル)エトキシ)フェニル)メタノール](/CAS/GIF/223251-16-9.gif) |
(4-(2-(アゼパン-1-イル)エトキシ)フェニル)メタノール |
223251-16-9 |
C15H23NO2 |
![4-ヒドロキシプロポホール](/CAS/GIF/1988-10-9.gif) |
4-ヒドロキシプロポホール |
1988-10-9 |
C12H18O2 |
![(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid](/CAS/20130318/GIF/CB82599546.gif) |
(1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarboxylic acid |
220352-36-3 |
C10H8F2O2 |
![N1-Methylbenzene-1,2,4-triaMine](/CAS/GIF/60651-29-8.gif) |
N1-Methylbenzene-1,2,4-triaMine |
60651-29-8 |
C7H11N3 |
![RocuroniuMbroMide iMpurity H](/) |
RocuroniuMbroMide iMpurity H |
|
|
![5-chloro-1-(3-diMethylaMinopropyl)-1-(4-fluorophenyl)-phthalan](/CAS/GIF/64169-45-5.gif) |
5-chloro-1-(3-diMethylaMinopropyl)-1-(4-fluorophenyl)-phthalan |
64169-45-5 |
C19H21ClFNO |
![dextroMethorphanone](/) |
dextroMethorphanone |
|
|
![oxiracetaM related substance ISF3886](/CAS/20180808/GIF/120428-80-0.gif) |
oxiracetaM related substance ISF3886 |
120428-80-0 |
C8H13N3O4 |
![Carvedilol IMpurity D](/CAS/GIF/1391052-16-6.gif) |
Carvedilol IMpurity D |
1391052-16-6 |
C39H39N3O6 |
![DL-2-(4-Carboxyphenyl)propionic Acid](/CAS/GIF/67381-50-4.gif) |
DL-2-(4-Carboxyphenyl)propionic Acid |
67381-50-4 |
C10H10O4 |
![ベタメタゾン17-プロピオン酸21-メシル酸](/CAS/GIF/15423-80-0.gif) |
ベタメタゾン17-プロピオン酸21-メシル酸 |
15423-80-0 |
C26H35FO8S |
![12-O-メチルクラリスロマイシン](/CAS/GIF/128940-83-0.gif) |
12-O-メチルクラリスロマイシン |
128940-83-0 |
C39H71NO13 |
![3(R)-Hydroperoxy Simvastatin](/CAS/GIF/1092716-42-1.gif) |
3(R)-Hydroperoxy Simvastatin |
1092716-42-1 |
C25H38O7 |
![10-デアセチル-10-オキソバッカチンV](/CAS/GIF/151636-94-1.gif) |
10-デアセチル-10-オキソバッカチンV |
151636-94-1 |
C29H34O10 |
![ドキシルアミン4-ピリジニル異性体](/CAS/GIF/873407-01-3.gif) |
ドキシルアミン4-ピリジニル異性体 |
873407-01-3 |
C17H22N2O |
![Clopidogrel EP IMpurity D](//CAS/20150408/GIF/1421283-60-4.gif) |
Clopidogrel EP IMpurity D |
1421283-60-4 |
C24H21Cl2NO4S |
![Loratadine IMpurity E](/CAS/20150408/GIF/CB82630382.gif) |
Loratadine IMpurity E |
|
C22H23ClN2O2 |
![Metoprolol IMpurity E](/CAS/20150408/GIF/CB82630397.gif) |
Metoprolol IMpurity E |
|
C15H25NO3 |
![IMp. A (EP): 4-Methyl-6-(1-Methyl-1H-benziMidazol-2-yl)-2-propyl-1H-benziMidazole](/) |
IMp. A (EP): 4-Methyl-6-(1-Methyl-1H-benziMidazol-2-yl)-2-propyl-1H-benziMidazole |
|
|
![(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester](/CAS/20150408/GIF/401566-80-1.gif) |
(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester |
401566-80-1 |
C27H38N6O3S |
![4-Methoxy-5-(3-Morpholinopropoxy)-2-nitrobenzaMide](/CAS/20150408/GIF/861453-16-9.gif) |
4-Methoxy-5-(3-Morpholinopropoxy)-2-nitrobenzaMide |
861453-16-9 |
C15H21N3O6 |
![5-chloro-3-sulfo-2-Thiophenecarboxylic acid](/CAS/20150408/GIF/187746-94-7.gif) |
5-chloro-3-sulfo-2-Thiophenecarboxylic acid |
187746-94-7 |
C5H3ClO5S2 |
![3,3'-diMethyl-1,1'-diphenyl-1H,1'H-4,4'-bipyrazole-5,5'-diol](/CAS/20180906/GIF/177415-76-8.gif) |
3,3'-diMethyl-1,1'-diphenyl-1H,1'H-4,4'-bipyrazole-5,5'-diol |
177415-76-8 |
C20H18N4O2 |
![5-(2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate](/CAS/20150408/GIF/1391194-39-0.gif) |
5-(2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
1391194-39-0 |
C20H20FNO3S |
![(S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide](/CAS/20150408/GIF/862894-96-0.gif) |
(S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
862894-96-0 |
C19H22N4O3 |
![Ticagrelor iMpurity](/CAS/20210111/GIF/1882095-51-3.gif) |
Ticagrelor iMpurity |
1882095-51-3 |
C27H45N5O8S |